Blackstone Inc Gritstone Bio, Inc. Transaction History

Blackstone Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.76 - $13.71 $76,746 - $120,113	-8,761 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$6.41 - $13.54 $56,158 - $118,623	8,761 New	8,761 $95,000
Q1 2021 May 17, 2021	SELL	$4.07 - $27.11 $10.4 Million - $69.6 Million	-2,567,445 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.61 - $31.1 $29.8 Million - $79.8 Million	2,567,445 New	2,567,445 $39.7 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

Stay updated on Blackstone Inc with notifications on news.